Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals, 9521-9522 [2023-03073]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 30 / Tuesday, February 14, 2023 / Notices
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2023–03124 Filed 2–13–23; 8:45 am]
BILLING CODE P
GENERAL SERVICES
ADMINISTRATION
[OMB Control No. 3090–XXXX; Docket No.
2023–0001; Sequence No. 1]
Information Collection; Overseas
Employment Agreement; GSA Form
5040
A. Purpose
Office of Human Resource
Management, Division of Human
Capital Policy and Programs, General
Services Administration (GSA).
ACTION: Notice of request for comments
regarding a request for a new OMB
clearance.
AGENCY:
Under the provisions of the
Paperwork Reduction Act, the
Regulatory Secretariat Division will be
submitting to the Office of Management
and Budget (OMB) a request to review
and approve a new information
collection requirement.
DATES: Submit comments on or before
April 17, 2023.
ADDRESSES: Submit comments
identified by Information Collection
3090–XXXX; Overseas Employment
Agreement; GSA Form 5040 to: https://
www.regulations.gov.
Submit comments via the Federal
eRulemaking portal by searching for
‘‘Information Collection 3090–XXXX;
Overseas Employment Agreement; GSA
Form 5040’’. Select the link ‘‘Submit a
Comment’’ that corresponds with
‘‘Information Collection 3090–XXXX;
Overseas Employment Agreement; GSA
Form 5040’’. Follow the instructions
provided at the ‘‘Submit a Comment’’
screen. Please include your name,
company name (if any), and
‘‘Information Collection 3090–XXXX;
Overseas Employment Agreement; GSA
Form 5040’’ on your attached document.
If your comment cannot be submitted
using https://www.regulations.gov, call
or email the points of contact in the FOR
FURTHER INFORMATION CONTACT section of
this document for alternate instructions.
Instructions: Please submit comments
only and cite Information Collection
3090–XXXX; Overseas Employment
Agreement; GSA Form 5040, in all
correspondence related to this
collection. Comments received generally
will be posted without change to https://
www.regulations.gov, including any
personal and/or business confidential
ddrumheller on DSK120RN23PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:12 Feb 13, 2023
Jkt 259001
information provided. To confirm
receipt of your comment(s), please
check www.regulations.gov,
approximately two-to-three days after
submission to verify posting.
FOR FURTHER INFORMATION CONTACT:
Colin C. Bennett, Human Resources
Specialist, Office of Human Resources
Management, Division of Human
Capital Policy and Programs, at
telephone 240–418–6822 or via email to
colin.bennett@gsa.gov for clarification of
content.
SUPPLEMENTARY INFORMATION:
The General Services Administration
routinely hires, reassigns, promotes or
transfers Federal employees to duty
stations in foreign areas (i.e., outside of
the United States and its territories and
possessions). Under the Administrative
Expenses Act of 1946 (60 Stat. 808), as
amended, agencies are permitted to use
appropriated funds to pay for the
various costs incurred for permanent
change of station (PCS) to the foreign
area (see further 5 U.S.C. 5722 et. seq.).
Such costs include: (1) travel expenses
of the new appointee (or employee) and
transportation expenses of his or her
immediate family and his household
goods and personal effects from the
place of actual residence at the time of
appointment to the place of
employment outside the continental
United States; (2) these expenses on the
return of an employee from his post of
duty outside the continental United
States to the place of his actual
residence at the time of assignment to
duty outside the continental United
States; and (3) the expenses of
transporting a privately owned motor
vehicle as authorized under 5 U.S.C.
5727(c). Under this authority, in return
for this travel and transportation benefit,
the appointee (or employee) must
remain in the agency’s service for 12
months (1 year). More information
concerning this statutory requirement is
found within the GSA Government
Travel Regulations at 41 CFR part 302–
3, subpart F.
In order to more effectively
memorialize the agency costs incurred,
and the appointee’s (or employee’s)
resulting service obligation, GSA has redeveloped its existing form GSA 5040.
The intent is for this form to be used:
(1) as an information collection device
to memorialize compensation, foreign
allowance, and travel and transportation
benefits provided, and (2) as an
enforceable service agreement for PCS
travel and transportation costs, pursuant
to the Federal Claims Collection Act of
1966 and the Debt Collection Act
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
9521
Amendments of 1996 (see further 31
U.S.C. 3711 et. seq.)
B. Annual Reporting Burden
Respondents: 25 per year.
Responses per Respondent: 1.
Total Annual Responses: 25.
Hours per Response: 1.
Total Burden Hours: 25.
C. Public Comments
Public comments are particularly
invited on: Whether this collection of
information is necessary, whether it will
have practical utility; whether our
estimate of the public burden of this
collection of information is accurate,
and based on valid assumptions and
methodology; ways to enhance the
quality, utility, and clarity of the
information to be collected; and ways in
which we can minimize the burden of
the collection of information on those
who are to respond, through the use of
appropriate technological collection
techniques or other forms of information
technology.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the Regulatory Secretariat Division by
calling 202–501–4755 or emailing
GSARegSec@gsa.gov. Please cite OMB
Control No. 3090–XXXX, Overseas
Employment Agreement; GSA Form
5040, in all correspondence.
Beth Anne Killoran,
Deputy Chief Information Officer.
[FR Doc. 2023–03131 Filed 2–13–23; 8:45 am]
BILLING CODE 6820–FM–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–2013–N–0134; FDA–
2016–D–2565; FDA–2013–N–0514; FDA–
2015–N–0030; FDA–2021–N–0584; FDA–
2021–N–1026; FDA–2013–N–0557; FDA–
2014–N–0053; FDA–2013–N–0190; FDA–
2019–N–0305; FDA–2019–N–2854; FDA–
2019–N–5553; FDA–2017–D–0085; FDA–
2016–N–2544; FDA–2019–N–2778; FDA–
2012–N–0977; FDA–2010–D–0319; and
FDA–2018–N–3728]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approvals
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is publishing a
list of information collections that have
been approved by the Office of
SUMMARY:
E:\FR\FM\14FEN1.SGM
14FEN1
9522
Federal Register / Vol. 88, No. 30 / Tuesday, February 14, 2023 / Notices
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
JonnaLynn Capezzuto, Office of
Operations, Food and Drug
Administration, Three White Flint
North, 10A–12M, 11601 Landsdown St.,
North Bethesda, MD 20852, 301–796–
3794, PRAStaff@fda.hhs.gov.
The
following is a list of FDA information
collections recently approved by OMB
under section 3507 of the Paperwork
Reduction Act of 1995 (44 U.S.C. 3507).
The OMB control number and
expiration date of OMB approval for
each information collection are shown
in table 1. Copies of the supporting
SUPPLEMENTARY INFORMATION:
statements for the information
collections are available on the internet
at https://www.reginfo.gov/public/do/
PRAMain. An Agency may not conduct
or sponsor, and a person is not required
to respond to, a collection of
information unless it displays a
currently valid OMB control number.
TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB
OMB control
No.
Title of collection
Mammography Standards Quality Act Requirements .............................................................................................
510(k) Third-Party Review Program ........................................................................................................................
Administrative Procedures for Clinical Laboratory Improvement Amendments of 1988 Categorization ................
Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act ......
Pilot to Develop Standardized Reporting Forms for Federally Funded Public Health Projects and Agreements
Text Analysis of Proprietary Drug Name Interpretations ........................................................................................
Postmarket Surveillance of Medical Devices ..........................................................................................................
Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods .....
Warning Plans for Smokeless Tobacco Products ...................................................................................................
Deeming Tobacco Products To Be Subject to the FD&C Act ................................................................................
Premarket Tobacco Product Applications and Recordkeeping Requirements .......................................................
Right to Try Act: Reporting Requirements ..............................................................................................................
Substances Generally Recognized as Safe: Best Practices for Convening a GRAS Panel ..................................
Medical Devices—Quality System Regulation; 21 CFR part 820 ...........................................................................
Threshold of Regulation for Substances Used in Food-Contact Articles ...............................................................
Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco to Protect Children
and Adolescents ...................................................................................................................................................
Mailing of Important Information About Drugs ........................................................................................................
Collection of Conflict of Interest Information for Participation in Food and Drug Administration Non-Employee
Fellowship and Traineeship Programs ................................................................................................................
Dated: February 8, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
patent which claims that human drug
product.
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–2018–E–3051 and FDA–
2018–E–3095]
Determination of Regulatory Review
Period for Purposes of Patent
Extension; ALIQOPA
AGENCY:
Notice.
The Food and Drug
Administration (FDA or the Agency) has
determined the regulatory review period
for ALIQOPA and is publishing this
notice of that determination as required
by law. FDA has made the
determination because of the
submission of applications to the
Director of the U.S. Patent and
Trademark Office (USPTO), Department
of Commerce, for the extension of a
ddrumheller on DSK120RN23PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:12 Feb 13, 2023
Jkt 259001
You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. The https://
www.regulations.gov electronic filing
system will accept comments until
11:59 p.m. Eastern Time at the end of
April 17, 2023. Comments received by
mail/hand delivery/courier (for written/
paper submissions) will be considered
timely if they are received on or before
that date.
ADDRESSES:
Food and Drug Administration,
HHS.
ACTION:
Anyone with knowledge that any
of the dates as published (see the
SUPPLEMENTARY INFORMATION section) are
incorrect may submit either electronic
or written comments and ask for a
redetermination by April 17, 2023.
Furthermore, any interested person may
petition FDA for a determination
regarding whether the applicant for
extension acted with due diligence
during the regulatory review period by
August 14, 2023. See ‘‘Petitions’’ in the
SUPPLEMENTARY INFORMATION section for
more information.
DATES:
[FR Doc. 2023–03073 Filed 2–13–23; 8:45 am]
Electronic Submissions
Submit electronic comments in the
following way:
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
Date approval
expires
0910–0309
0910–0375
0910–0607
0910–0800
0910–0909
0910–0910
0910–0449
0910–0560
0910–0671
0910–0768
0910–0879
0910–0893
0910–0911
0910–0073
0910–0298
11/30/2025
11/30/2025
11/30/2025
11/30/2025
11/30/2025
11/30/2025
12/31/2025
12/31/2025
12/31/2025
12/31/2025
12/31/2025
12/31/2025
12/31/2025
1/31/2026
1/31/2026
0910–0312
0910–0754
1/31/2026
1/31/2026
0910–0882
1/31/2026
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
E:\FR\FM\14FEN1.SGM
14FEN1
]]>Agencies
[Federal Register Volume 88, Number 30 (Tuesday, February 14, 2023)]
[Notices]
[Pages 9521-9522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03073]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2013-N-0134; FDA-2016-D-2565; FDA-2013-N-0514; FDA-
2015-N-0030; FDA-2021-N-0584; FDA-2021-N-1026; FDA-2013-N-0557; FDA-
2014-N-0053; FDA-2013-N-0190; FDA-2019-N-0305; FDA-2019-N-2854; FDA-
2019-N-5553; FDA-2017-D-0085; FDA-2016-N-2544; FDA-2019-N-2778; FDA-
2012-N-0977; FDA-2010-D-0319; and FDA-2018-N-3728]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
information collections that have been approved by the Office of
[[Page 9522]]
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-3794,
[email protected].
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
OMB control Date approval
Title of collection No. expires
------------------------------------------------------------------------
Mammography Standards Quality Act 0910-0309 11/30/2025
Requirements...........................
510(k) Third-Party Review Program....... 0910-0375 11/30/2025
Administrative Procedures for Clinical 0910-0607 11/30/2025
Laboratory Improvement Amendments of
1988 Categorization....................
Human Drug Compounding Under Sections 0910-0800 11/30/2025
503A and 503B of the Federal Food,
Drug, and Cosmetic Act.................
Pilot to Develop Standardized Reporting 0910-0909 11/30/2025
Forms for Federally Funded Public
Health Projects and Agreements.........
Text Analysis of Proprietary Drug Name 0910-0910 11/30/2025
Interpretations........................
Postmarket Surveillance of Medical 0910-0449 12/31/2025
Devices................................
Establishment, Maintenance, and 0910-0560 12/31/2025
Availability of Records; Additional
Traceability Records for Certain Foods.
Warning Plans for Smokeless Tobacco 0910-0671 12/31/2025
Products...............................
Deeming Tobacco Products To Be Subject 0910-0768 12/31/2025
to the FD&C Act........................
Premarket Tobacco Product Applications 0910-0879 12/31/2025
and Recordkeeping Requirements.........
Right to Try Act: Reporting Requirements 0910-0893 12/31/2025
Substances Generally Recognized as Safe: 0910-0911 12/31/2025
Best Practices for Convening a GRAS
Panel..................................
Medical Devices--Quality System 0910-0073 1/31/2026
Regulation; 21 CFR part 820............
Threshold of Regulation for Substances 0910-0298 1/31/2026
Used in Food-Contact Articles..........
Regulations Restricting the Sale and 0910-0312 1/31/2026
Distribution of Cigarettes and
Smokeless Tobacco to Protect Children
and Adolescents........................
Mailing of Important Information About 0910-0754 1/31/2026
Drugs..................................
Collection of Conflict of Interest 0910-0882 1/31/2026
Information for Participation in Food
and Drug Administration Non-Employee
Fellowship and Traineeship Programs....
------------------------------------------------------------------------
Dated: February 8, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-03073 Filed 2-13-23; 8:45 am]
BILLING CODE 4164-01-P
